Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $189K | $1.98M | $437K | $1.26M | $3.11M | $3.05M |
| Revenue growth | — | 949.3% | -77.9% | 187.5% | 147.6% | -1.9% |
| Gross profit | — | — | — | $327K | $1.43M | $1.25M |
| Gross margin | — | — | — | 26.0% | 45.8% | 40.8% |
| Operating income | -$2.86M | -$5.57M | -$8.34M | -$12.6M | -$10.3M | -$10.6M |
| Operating margin | -1513.7% | -281.4% | -1907.1% | -1002.1% | -330.5% | -348.7% |
| Net income | -$3.16M | -$7.04M | -$8.31M | -$10.6M | -$10.2M | -$10.6M |
| Net margin | -1676.2% | -355.3% | -1900.1% | -845.9% | -326.4% | -346.2% |
| EPS (diluted) | -$0.37 | -$0.68 | -$11.33 | -$127.00 | -$6.38 | -$2.00 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$499K | -$11.3M | -$3.36M | -$7.38M | -$9.57M | -$9.68M |
| Capital expenditures | — | — | — | — | $221K | $232K |
| Free cash flow | — | — | — | — | -$9.79M | -$9.91M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $427K | $12.6M | $8.24M | $1.54M | $6.30M | $1.02M |
| Total assets | $2.48M | $21.9M | $12.4M | $10.4M | $13.8M | $8.25M |
| Total liabilities | $7.69M | $6.85M | $5.81M | $6.67M | $5.60M | $5.44M |
| Long-term debt | — | — | — | — | $1.65M | — |
| Shareholders' equity | -$5.19M | $15.1M | $6.62M | $3.80M | $8.33M | $3.00M |
| Retained earnings | -$15.8M | -$22.9M | -$31.2M | -$41.8M | -$52.0M | -$62.5M |
| Shares (wtd avg diluted) | 8.63M | 10.4M | 733K | 83.7B | 1.59M | 5.27M |
Every figure is extracted from INTELLIGENT BIO SOLUTIONS INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.